Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by University Hospital, Clermont-Ferrand.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborators:
H. Lundbeck A/S, TEVA
CHU Purpan (Toulouse)
Hôpital Haut-Lévêque
Centre Hospitalier de la côte Basque
Poitiers University Hospital
CHU de Rennes (Rennes)
University Hospital, Lille
Hôpital Dupuytren
University Hospital, Caen
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier du Pays d'Aix
Hôpital de la Timone (MARSEILLE)
University Hospital, Rouen
Centre Hospitalier Universitaire, Amiens
Centre Hospitalier Universitaire de Saint Etienne
Fondation Rothschild Paris
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT01765257
First received: January 8, 2013
Last updated: January 9, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)